Financials
- Market Capitalization 13.88 M
- Employee 7
- Founded 2012
- CEO N/A
- Website www.intensitytherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00B57FZV6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4674 | PASG Passage Bio, Inc. - Common Stock | 4.52 USD | +4.39% | -3.00% | +0.89% | -48.87% | 14.54 M USD | ||
| 4678 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.42 USD | -4.55% | +10.53% | -12.50% | -60.00% | 13.67 M USD | ||
| 4697 | ICU SeaStar Medical Holding Corporation - Common Stock | 3.09 USD | -0.32% | -8.85% | -6.36% | +25.61% | 13.62 M USD | ||
| 4699 | GTBP GT Biopharma, Inc. - Common Stock | 0.30 USD | 0.00% | +3.45% | 0.00% | -67.74% | 13.53 M USD |
Frequently asked questions about Intensity Therapeutics, Inc. Common stock
What is the Intensity Therapeutics, Inc. Common stock stock price today?
The current price of Intensity Therapeutics, Inc. Common stock (INTS) is 4.25. Over the past 24 hours, the stock has changed by -0.47%. Follow the INTS chart for real-time price dynamics.
What is the stock ticker of Intensity Therapeutics, Inc. Common stock?
Intensity Therapeutics, Inc. Common stock trades under the ticker INTS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Intensity Therapeutics, Inc. Common stock stock going up?
INTS has changed by -7.00% over the last week, -1.39% over the last month, and +1417.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Intensity Therapeutics, Inc. Common stock?
Intensity Therapeutics, Inc. Common stock currently has a market capitalization of 13.88 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Intensity Therapeutics, Inc. Common stock earnings last quarter?
Last quarter, Intensity Therapeutics, Inc. Common stock reported earnings of -1.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Intensity Therapeutics, Inc. Common stock net income for the last quarter?
Intensity Therapeutics, Inc. Common stock reported net income of -3.01 M for the last quarter. The previous quarter showed -2.43 M, which means net income changed by -23.54%.
How many employees does Intensity Therapeutics, Inc. Common stock have?
As of the latest available data, Intensity Therapeutics, Inc. Common stock has 7 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Intensity Therapeutics, Inc. Common stock stock?
You can buy Intensity Therapeutics, Inc. Common stock (INTS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Intensity Therapeutics, Inc. Common stock stock?
Investing in Intensity Therapeutics, Inc. Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INTS chart and related analysis on metatrader.com as part of your research.